The regulation of signal transduction events following tissue injury is of prime importance in maintaining cell viability. This process is particularly relevant to diseases of the respiratory and cardiovascular system, where tissue insults such as ischemia, reperfusion, and sepsis are common. The applicants propose that this occurs through the involvement of the 90-kDa heat-shock protein hsp9O. Hsp9O is an abundant and ubiquitously distributed stress protein present in all living organisms from bacteria to man. Although hsp9O plays a role in steroid receptor maturation, and forms stable associations with several protein kinases, no clear picture regarding hsp9O's exact function at the molecular level has emerged. In this proposal, they hypothesize that hsp9O functions as a protein kinase chaperone, assisting in the correct packing of the regulatory and catalytic domains. By sequestering the catalytic subunits of a variety of protein kinases following injury, hsp9O could prevent both non-specific kinase denaturation/aggregation and the inappropriate activation of signal transduction pathways. In vivo cell culture experiments will be used to determine the identity and activity of protein kinases that interact with hsp9O following injury. In vitro protein biochemistry experiments will examine which kinase subfamilies contain members capable of interacting with hsp9O, and elucidate whether hsp9O plays a chaperone-like function in this interaction. Finally the mechanism of hsp9O kinase binding and release will be investigated using kinase mutants, domain- and loop-swapping constructs, and oriented peptide libraries, based on extrapolations from known protein kinase crystal structures.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08HL003601-03
Application #
6078019
Study Section
Special Emphasis Panel (ZHL1-CSR-Y (O1))
Project Start
1997-09-30
Project End
2000-09-29
Budget Start
1999-09-30
Budget End
2000-09-29
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
076593722
City
Boston
State
MA
Country
United States
Zip Code
02215
Yaffe, M B; Leparc, G G; Lai, J et al. (2001) A motif-based profile scanning approach for genome-wide prediction of signaling pathways. Nat Biotechnol 19:348-53
Bedford, M T; Frankel, A; Yaffe, M B et al. (2000) Arginine methylation inhibits the binding of proline-rich ligands to Src homology 3, but not WW, domains. J Biol Chem 275:16030-6
Durocher, D; Smerdon, S J; Yaffe, M B et al. (2000) The FHA domain in DNA repair and checkpoint signaling. Cold Spring Harb Symp Quant Biol 65:423-31
Bedford, M T; Sarbassova, D; Xu, J et al. (2000) A novel pro-Arg motif recognized by WW domains. J Biol Chem 275:10359-69
Benzing, T; Yaffe, M B; Arnould, T et al. (2000) 14-3-3 interacts with regulator of G protein signaling proteins and modulates their activity. J Biol Chem 275:28167-72
Trainor, C D; Ghirlando, R; Simpson, M A (2000) GATA zinc finger interactions modulate DNA binding and transactivation. J Biol Chem 275:28157-66
Bunnell, S C; Diehn, M; Yaffe, M B et al. (2000) Biochemical interactions integrating Itk with the T cell receptor-initiated signaling cascade. J Biol Chem 275:2219-30
Datta, S R; Katsov, A; Hu, L et al. (2000) 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell 6:41-51
Durocher, D; Taylor, I A; Sarbassova, D et al. (2000) The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms. Mol Cell 6:1169-82
Kanai, F; Marignani, P A; Sarbassova, D et al. (2000) TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 19:6778-91

Showing the most recent 10 out of 12 publications